Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeName |
PTI-125
|
| gptkbp:clinicalTrialPhase |
Phase 3 (as of 2024)
|
| gptkbp:countryOfOrigin |
gptkb:United_States
|
| gptkbp:developedBy |
gptkb:Cassava_Sciences
|
| gptkbp:intendedUse |
gptkb:Alzheimer's_disease
|
| gptkbp:mechanismOfAction |
binds altered filamin A
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
mild-to-moderate Alzheimer's disease
|
| gptkbp:bfsParent |
gptkb:Cassava_Sciences
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
simufilam
|